<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03064321</url>
  </required_header>
  <id_info>
    <org_study_id>K24NR016685-01A1</org_study_id>
    <nct_id>NCT03064321</nct_id>
  </id_info>
  <brief_title>Diabetes Sleep Treatment Trial for Insomnia</brief_title>
  <acronym>DSTT-I</acronym>
  <official_title>Self-Management, Insomnia, and Glucose Control in Adults With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the effect of the an insomnia intervention with cognitive behavioral&#xD;
      treatment delivered via web compared with an information control group on glucose control and&#xD;
      self management behavioral in a sample of persons with type 2 diabetes (T2DM).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent evidence supports that insomnia is a prevalent problem among persons with type 2&#xD;
      diabetes that may be associated with increased daytime sleepiness and fatigue, increased&#xD;
      diabetes-related distress, decreased self-management behavior, and worse glycemic control.&#xD;
      The main hypothesis of the current application is that a web-based cognitive behavioral&#xD;
      treatment of insomnia (Sleep Health Using the Internet: SHUTi) in persons with T2DM will not&#xD;
      only improve their nighttime sleep, but also improve their ability to integrate diabetes&#xD;
      education into their daily behavior and positively affect their glucose control compared to a&#xD;
      web-based Information Control (IC) group. The aims of this study are to 1) obtain preliminary&#xD;
      data to facilitate further hypothesis development and enhance the feasibility of conducting a&#xD;
      randomized clinical trial to examine if treatment of insomnia results in participant's being&#xD;
      better able to integrate diabetes education into their self-management behavior and result in&#xD;
      improved glucose control, 2) explore the associations among changes in insomnia severity,&#xD;
      fatigue, daytime sleepiness, sleep quality, A1C (a measure of glucose control over the last&#xD;
      three months) and diabetes self-management (DSM) behaviors, 3) explore average&#xD;
      pre-intervention to post-intervention changes in insomnia severity, daytime symptoms&#xD;
      (fatigue, sleepiness, mood) and DSM behaviors (diet and physical activity) in subjects&#xD;
      treated with SHUTi + DSM compared to IC + DSM subjects at 3 months, and 4) explore sleep&#xD;
      fragmentation as a potential physiological mechanism linking impaired glucose control (A1C)&#xD;
      and sleep in subjects with insomnia and T2DM at baseline and 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Actual">March 30, 2020</completion_date>
  <primary_completion_date type="Actual">March 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two group design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average Glucose Control for Last 3 Months Assessed by A!C level</measure>
    <time_frame>After 12 weeks of either the insomnia intervention or the information control intervention</time_frame>
    <description>A1C level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>After 12 weeks of either the insomnia intervention or the information control intervention</time_frame>
    <description>Scores on the Pittsburgh Sleep Quality Index questionnaire</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Insomnia Severity</measure>
    <time_frame>After 12 weeks of either the insomnia intervention or the information control intervention</time_frame>
    <description>Scores on the Insomnia Severity Index questionnaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Insomnia</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Insomnia Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insomnia intervention delivered via web using Cognitive Behavior Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>General health information website</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Insomnia Intervention</intervention_name>
    <description>The SHUTi intervention is based on a cognitive behavioral treatment for insomnia (CBT-I) and organized into six structured, weekly online sessions. Each week the participants will complete a 30-minute interactive learning module and to complete daily online sleep diaries will be used.</description>
    <arm_group_label>Insomnia Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Information Control</intervention_name>
    <description>Information on websites that are general health promoting</description>
    <arm_group_label>Information Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  (1) T2DM with suboptimal glucose control&#xD;
&#xD;
          -  (2) age 18 years or older;&#xD;
&#xD;
          -  (3) willing to be randomized to SHUTi or IC group;&#xD;
&#xD;
          -  (4) able to speak, read, and write in English, and&#xD;
&#xD;
          -  (5) insomnia symptoms with at least one daytime consequence [e.g. impaired mood, poor&#xD;
             sleep quality, excessive daytime sleepiness, fatigue].&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Type 1 or gestational diabetes&#xD;
&#xD;
          -  Change in oral medications or &gt; 10% change in insulin in last 3 months&#xD;
&#xD;
          -  Acute medical or psychiatric illness or hospitalization ≤ 3 months (such as angina,&#xD;
             stroke, major surgery, major depression or serious psychiatric conditions)&#xD;
&#xD;
          -  AHI (apnea-hypopnea index; apnea [cessation of breathing] or hypopnea [reduction in&#xD;
             breathing]) ≥ 10 episodes an hour on overnight sleep study&#xD;
&#xD;
          -  Non-ambulatory&#xD;
&#xD;
          -  Self-reported epilepsy, psychotic or bipolar disorder&#xD;
&#xD;
          -  History of near-miss or auto accident during last 12 months&#xD;
&#xD;
          -  Employed in safety sensitive job (e.g. truck driver or airline pilot)&#xD;
&#xD;
          -  Working nights or rotating shifts&#xD;
&#xD;
          -  Regular use of alerting (e.g., modafinil) medications&#xD;
&#xD;
          -  Consumption of alcohol: Men: &gt; 4 drinks a day or &gt; 14 drinks per week&#xD;
&#xD;
          -  Women: &gt; 3 drinks a day or &gt; 7 drinks per week&#xD;
&#xD;
          -  If using sleep medications, the drug and/or dose changed in the past month&#xD;
&#xD;
          -  Depression&#xD;
&#xD;
          -  Medications for psychotic or bipolar disorders&#xD;
&#xD;
          -  No internet access&#xD;
&#xD;
          -  Pregnant or intend to become pregnant in the next four months (postmenopausal or&#xD;
             confirmed not pregnant by a urine pregnancy test)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eileen R Chasens</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh School of Nursing</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2017</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Eileen R. Chasens</investigator_full_name>
    <investigator_title>Associate Professor of Nursing</investigator_title>
  </responsible_party>
  <keyword>cognitive behavioral treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

